Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Sand Grove Capital Management LLP

Sand Grove Capital Management LLP lowered its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 21.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 340,056 shares of the health services provider's stock after selling 95,010 shares during the period. Amedisys makes up about 12.8% of Sand Grove Capital Management LLP's investment portfolio, making the stock its biggest position. Sand Grove Capital Management LLP owned approximately 1.04% of Amedisys worth $32,819,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Alpine Associates Management Inc. raised its holdings in Amedisys by 0.9% in the 2nd quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider's stock valued at $117,586,000 after acquiring an additional 11,000 shares during the last quarter. Westchester Capital Management LLC increased its stake in shares of Amedisys by 9.5% during the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider's stock valued at $107,976,000 after acquiring an additional 97,476 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider's stock worth $47,202,000 after acquiring an additional 19,660 shares during the period. Calamos Advisors LLC grew its holdings in Amedisys by 11.6% in the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider's stock valued at $36,476,000 after purchasing an additional 41,220 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in Amedisys by 2.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider's stock worth $33,400,000 after purchasing an additional 9,004 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Trading Up 0.1 %

NASDAQ AMED traded up $0.06 during mid-day trading on Thursday, hitting $85.04. The company's stock had a trading volume of 634,827 shares, compared to its average volume of 370,202. The firm has a market capitalization of $2.79 billion, a P/E ratio of 33.72, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 52-week low of $84.06 and a 52-week high of $98.95. The stock's fifty day simple moving average is $94.17 and its two-hundred day simple moving average is $95.46.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $0.98 earnings per share. Research analysts expect that Amedisys, Inc. will post 4.53 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.